Implications loom large in human gene patent case before US Supreme Court (w/ video)

Apr 12, 2013

A human gene patenting case before the U.S. Supreme Court next week could have major implications for biotechnology research and the public interest in the nation's patent system, according to a University of Michigan expert.

Shobita Parthasarathy, associate professor at the Ford School of Public Policy, whose expert declaration on behalf of the plaintiffs was heavily cited by the district court that initially reviewed the case, says that major issues at stake include the basic question of whether are considered products of nature.

This video is not supported by your browser at this time.

"If they are, then according to the U.S. law, they can't be patented," she said. "In addition, there are major policy issues at stake. As the patent system has grown, it has become clear that it has mixed results for innovation, for society, for our values and for the economy."

The case began in 2009 when a coalition of scientists, physicians and patient advocacy groups represented by the filed suit against biotech company Myriad Genetics and the U.S. , challenging the patentability of genes linked to breast and ovarian cancer.

These groups alleged that Myriad's patents are invalid under Supreme Court precedent because they are "products of nature" and that they limit patient access to testing, increase health care costs, jeopardize testing quality, interfere with and privatize what once were public goods.

"In the breast cancer case, for example, a gene patent allows one company to control all genetic testing for in the United States," Parthasarathy said.

"What I hope is that we've started an ongoing discussion about how the serves the public interest because this is only one out of many controversies that are going on regarding patents on life-forms, patents on essential medicines and patents on information and communication technologies like the iPad."

The Supreme Court is expected to hear the case on April 15. Parthasarathy expects to attend and is available for media interviews before or after the session.

Explore further: The origin of the language of life

add to favorites email to friend print save as pdf

Related Stories

High court throws out human gene patents

Mar 26, 2012

(AP) -- The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.

US court to decide if human genes can be patented

Nov 30, 2012

The Supreme Court announced Friday it will decide whether companies can patent human genes, a decision that could reshape medical research in the United States and the fight against diseases like breast and ovarian cancer.

Myriad can patent breast cancer genes: US court

Jul 30, 2011

A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.

US judge strikes down patent on cancer genes

Mar 29, 2010

(AP) -- In a ruling with potentially far-reaching implications for the patenting of human genes, a judge on Monday struck down a company's patents on two genes linked to an increased risk of breast and ovarian cancer.

Recommended for you

The origin of the language of life

Dec 19, 2014

The genetic code is the universal language of life. It describes how information is encoded in the genetic material and is the same for all organisms from simple bacteria to animals to humans. However, the ...

Quest to unravel mysteries of our gene network

Dec 18, 2014

There are roughly 27,000 genes in the human body, all but a relative few of them connected through an intricate and complex network that plays a dominant role in shaping our physiological structure and functions.

EU court clears stem cell patenting

Dec 18, 2014

A human egg used to produce stem cells but unable to develop into a viable embryo can be patented, the European Court of Justice ruled on Thursday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.